Related references
Note: Only part of the references are listed.COVID-19 in Italian patients with rheumatic autoimmune systemic diseases
Clodoveo Ferri et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis
Wen Wen et al.
ANNALS OF MEDICINE (2022)
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2
Marcella Visentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases
Francesco Ursini et al.
CLINICAL RHEUMATOLOGY (2022)
COVID-19 Therapeutics for Nonhospitalized Patients
Rajesh T. Gandhi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination
G. Fiorillo et al.
JOURNAL OF AUTOIMMUNITY (2022)
COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Inter net-Based Survey
Richard Tsai et al.
JMIR PUBLIC HEALTH AND SURVEILLANCE (2022)
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life
Laura Gragnani et al.
AUTOIMMUNITY REVIEWS (2022)
First-generation oral antivirals against SARS-CoV-2
Parham Sendi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Rebecca Grainger et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination
Caoilfhionn M. Connolly et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
Laura Boekel et al.
LANCET RHEUMATOLOGY (2021)
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
Laura Boekel et al.
LANCET RHEUMATOLOGY (2021)
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
Jerome Avouac et al.
LANCET RHEUMATOLOGY (2021)
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Clodoveo Ferri et al.
JOURNAL OF AUTOIMMUNITY (2021)
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Einav G. Levin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study
Jing Sha et al.
FRONTIERS IN MEDICINE (2021)
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
Brian J. Boyarsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
Michael Markus Bonelli et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
Ulf M. Geisen et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Youn Ho Shin et al.
LANCET RHEUMATOLOGY (2021)
Cutaneous vasculitis following COVID-19 vaccination
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2021)
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
Yolanda Braun-Moscovici et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
Jake A. Ruddy et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry (vol 7, e001461, 2021)
C. D. L. Marques et al.
RMD OPEN (2021)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
Jose L. Pablos et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
Dalifer D. Freites Nunez et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
Clodoveo Ferri et al.
CLINICAL RHEUMATOLOGY (2020)
Cryoglobulinemia: An update in 2019
Anne Claire Desbois et al.
JOINT BONE SPINE (2019)
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis
L. Gragnani et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Human autoimmune diseases: a comprehensive update
Lifeng Wang et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer
Clodoveo Ferri et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Validation of the classification criteria for cryoglobulinaemic vasculitis
Luca Quartuccio et al.
RHEUMATOLOGY (2014)
B-cells and mixed cryoglobulinemia
Clodoveo Ferri et al.
AUTOIMMUNITY REVIEWS (2007)
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients
C Ferri et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Cryoglobulinemia -: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center
O Trejo et al.
MEDICINE (2001)